Evidence map›Paper›PMID 41795740›Full record

ArticleWorld journal of urology2026

Immediate Vs. Delayed single post-operative intravesical instillation of chemotherapy in reducing bladder recurrence rate in upper tract urothelial carcinoma patients after radical nephroureterectomy.

Yiwen Liu, Yun Song, Nienie Qi, Chong Han, Meng Lu, Meng Zhang, Rumin Wen, Xiaoxiao Jiang, Hailong Li

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yiwen LiuDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yun SongFeng Xian People's Hospital, Xuzhou, China.
Nienie QiDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chong HanDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Meng LuDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Meng ZhangDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Rumin WenDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. wenrumin163@163.com.
Xiaoxiao JiangYancheng No.1 People's Hospital, Yancheng, China. 401774138@qq.com.
Hailong LiDepartment of Urology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. justinlee719@163.com.

Funding

Advanced Program of The Affiliated Hospital of Xuzhou Medical University 2024104192Construction Project of High Level Hospital of Jiangsu Province LCZX202407Innovation and entrepreneurship projects at the Xuzhou Medical University Science and Technology Park CXCYYB202413Jiangsu Province Postdoctoral Innovation Practice Base Medical Science and Technology Innovation Project SRYKTH202402Key Medical Research Projects of Jiangsu Provincial Health Commission K2024040National Nature Science Foundation of China Youth Project 81502193Post-doctoral Research Funding Project in Jiangsu Province 2021K447CResearch project on the "Pairing Assistance" initiative at the Affiliated Hospital of Xuzhou Medical University FXJDBF2024104Six Talent Peaks Project in Jiangsu Province WSW-064
6 · The paper itself

Abstract

objectiveTo evaluate the impact of immediate single dose intravesical instillation after operation on bladder recurrence in upper tract urothelial carcinoma patients after radical nephroureterectomy.

methodsA retrospective analysis was performed on clinical data of upper tract urothelial carcinoma patients who underwent radical nephroureterectomy at our center from December 2013 to December 2023. All patients undergo single-dose intravesical instillation (The instillation agent were pirarubicin or epirubicin) after surgery. Patients were divided into two groups based on the time of undergoing single dose postoperative intravesical instillation: the immediate instillation group (within 24 h after the operation) and the delayed group (2-10days after the operation). The primary observation indicator was postoperative bladder recurrence-free survival. Baseline characteristics of the two groups were balanced using propensity score matching (PSM). The Kaplan-Meier method was used to plot survival curves, and the Log-rank test was applied to compare differences between groups. Cox proportional hazards regression model was used to analyze risk factors for postoperative bladder recurrence.

resultsA total of 418 patients were included (115 in the immediate instillation group and 303 in the delayed instillation group). After propensity score matching (PSM), 101 patients were successfully matched in each group. The 2-year bladder recurrence-free survival rate was significantly higher in the immediate instillation group (84.2%) than in the delayed instillation group (77.2%, P = 0.004). Subgroup analysis showed: among patients who underwent preoperative ureteroscopy, the bladder recurrence-free survival rate was 76.7% in the immediate instillation group vs. 48.0% in the delayed instillation group (P = 0.035); among patients without preoperative ureteroscopy, the bladder recurrence-free survival rate was 87.3% in the immediate instillation group vs. 73.7% in the delayed instillation group (P = 0.029). There was no difference in instillation-related adverse events between the two groups.

conclusionWhether ureteroscopy is performed preoperatively or not, a single immediate bladder instillation after operation can effectively reduce the bladder recurrence rate in upper tract urothelial carcinoma patients after radical nephroureterectomy compared with delayed instillation.

Indexed as

Antineoplastic AgentsCarcinoma, Transitional CellDoxorubicinEpirubicinKidney NeoplasmsNeoplasm Recurrence, LocalNephroureterectomyUreteral NeoplasmsUrinary Bladder NeoplasmsAdministration, IntravesicalAgedFemaleHumansMaleMiddle AgedPostoperative CareAntineoplastic AgentsDoxorubicinEpirubicinpirarubicinIntravesical instillationIntravesical recurrenceRadical nephroureterectomyUpper urinary tract urothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.